Krystal Biotech KRYS
NASDAQ KRYS
$323.96 +1.79 (+0.56%)
As of: Oct 22, 2026 · 9:38 AM EDT

Krystal Biotech (KRYS) Deferred Taxes (2025)

Updated

Krystal Biotech's Deferred Taxes came in at -$1.84 million for Q4 2025.

Analysis

Krystal Biotech (KRYS) Deferred Taxes (2025) Analysis & Trends

For FY2025, Krystal Biotech's Deferred Taxes was $22.85 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn -479.00 Mn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn -195.00 Mn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn -
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn -
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn -587.00 Mn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn -1.32 Bn
10 Krystal Biotech 9.57 Bn 6.34 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.84 Mn
API Access

Krystal Biotech Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=KRYS&period=max&api_key=YOUR_API_KEY